Christopher J. Perkins, MD

Instructor, Medicine

Christopher Perkins
660 Harrison Ave


Christopher Perkins, MD is an Instructor of Medicine at Boston University School of Medicine. Dr. Perkins received his degree from the Boston University School of Medicine also completed his residency at Boston Medical Center. He is board certified in internal medicine. His interests include adult primary care and internal medicine.

Other Positions

  • Norwood Hospital
  • Boston University Affiliated Physicians, Inc.



  • Boston University School of Medicine, MD
  • Boston University, MA
  • Colby College, BA


  • Published on 11/17/2015

    Nauck MA, Stewart MW, Perkins C, Jones-Leone A, Yang F, Perry C, Reinhardt RR, Rendell M. Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise. Diabetologia. 2016 Feb; 59(2):266-74. PMID: 26577795.

    Read at: PubMed
  • Published on 8/1/1996

    Barat LM, Gunn JE, Steger KA, Perkins CJ, Craven DE. Causes of fever in patients infected with human immunodeficiency virus who were admitted to Boston City Hospital. Clin Infect Dis. 1996 Aug; 23(2):320-8. PMID: 8842271.

    Read at: PubMed
  • Published on 7/1/1990

    Cooley TP, Kunches LM, Saunders CA, Perkins CJ, Kelley SL, McLaren C, McCaffrey RP, Liebman HA. Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once daily. Rev Infect Dis. 1990 Jul-Aug; 12 Suppl 5:S552-60. PMID: 1974727.

    Read at: PubMed
  • Published on 5/10/1990

    Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N Engl J Med. 1990 May 10; 322(19):1340-5. PMID: 2139174.

    Read at: PubMed

View all profiles